Stryker Corporation (SYK)

NYSE · Health Care · Medical Devices
By Alex · Tickerpine
$347.21
-0.94 (-0.27%)
Price — last 10 years monthly, dividend-adjusted · hover for detail
Market Cap
$133.18B
P/E (TTM)
36.1
Forward P/E
20.7
EPS (TTM)
$9.62
ROE
16.51%
Profit Margin
14.43%
Revenue Growth
9.40%
Dividend Yield
1.01%
Beta
0.77
52W High
$396.86
52W Low
$281.00
Analyst Target
$382.04

SYK stock forecast: what analysts expect

Consensus rating
Buy
Avg. 12-month target
$382.04
Implied upside
+10.0%

Wall Street analysts covering Stryker Corporation currently rate the stock a Buy on average, with a mean 12-month price target of $382.04 — +10.0% versus the last price of $347.21. Targets reflect analyst opinion, not a guarantee.

What would an investment in SYK be worth today?
Run SYK through our free historical return calculator.
Calculate SYK returns →

SYK historical returns

PeriodTotal returnAnnualized (CAGR)$1,000 grew to
1 year -10.4% -10.4% $896
3 years +26.1% +8.0% $1,261
5 years +32.0% +5.7% $1,320
10 years +235% +12.9% $3,353
20 years +809% +11.7% $9,091
Since 1985 +113,367% +18.4% $1,134,673

Based on monthly dividend-adjusted prices. See the full breakdown on what if you had invested in SYK.

SYK annual returns by year

2026 YTD -0.7%
2025 -1.5%
2024 +21.3%
2023 +23.8%
2022 -7.4%
2021 +10.2%
2020 +18.2%
2019 +35.3%
2018 +2.4%
2017 +30.8%

Congress trading in SYK

13 members of Congress have disclosed trading SYK — 20 purchases and 6 sales worth an estimated $607,000. Most recent disclosure: Dec 10, 2025.

See who in Congress traded SYK →

Insider activity in SYK

SYK's own executives and directors have made 0 open-market purchases ($0) and 12 sales ($98.2M) in the last 90 days, per SEC Form 4 filings. Most recent: May 28, 2026.

May 28, 2026Fletcher Robert S VP, Chief Legal Officer Sell $36,507
May 28, 2026Fletcher Robert S VP, Chief Legal Officer Sell $50,434
May 28, 2026Fletcher Robert S VP, Chief Legal Officer Sell $861,138
May 28, 2026Fletcher Robert S VP, Chief Legal Officer Sell $327,886
May 28, 2026Fletcher Robert S VP, Chief Legal Officer Sell $79,667

About Stryker Corporation

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Company website ↗

SYK Key Statistics

Previous Close$348.15P/E Ratio36.1
Market Cap$133.18BPEG Ratio1.63
Revenue (TTM)$25.84BROE16.51%
Gross Margin65.59%ROA8.16%
Debt / Equity64.4Employees56,000

SYK in plain English

SYK stock: frequently asked questions

What is Stryker Corporation's stock price today?

Stryker Corporation (SYK) last traded at $347.21 on the NYSE. Over the past 52 weeks the stock has traded between $281.00 and $396.86.

Is SYK stock a buy or a sell?

Wall Street analysts' consensus rating on SYK is "Buy", with an average 12-month price target of $382.04 — about +10.0% versus the current price of $347.21. Analyst targets are opinions, not guarantees; always do your own research.

How much would $1,000 invested in SYK 10 years ago be worth today?

A $1,000 investment in Stryker Corporation made 10 years ago would be worth about $3,353 today (dividends reinvested) — a total return of 235%, or 12.9% per year.

Does SYK pay a dividend?

Yes. Stryker Corporation currently pays a dividend yielding about 1.01% per year at today's share price.

What is SYK's P/E ratio?

SYK trades at a trailing price-to-earnings ratio of 36.1, and 20.7 times expected forward earnings. The P/E ratio tells you how many dollars investors pay for each $1 of the company's annual profit.

Do members of Congress trade SYK stock?

Yes — 13 members of Congress have disclosed trades in SYK under the STOCK Act, totaling 20 purchases and 6 sales worth an estimated $607,000.

What is Stryker Corporation's ticker symbol?

Stryker Corporation trades under the ticker symbol SYK on the NYSE.

Compare SYK with peers

SYK vs LLYEli Lilly and Company $1,220.28 SYK vs JNJJohnson & Johnson $260.86 SYK vs ABBVAbbVie Inc. $248.76 SYK vs UNHUnitedHealth Group Incorporated $405.59 SYK vs MRKMerck & Company, Inc. $132.92

Data last refreshed from public sources. Figures may be delayed. Not investment advice.